Schott Pharma stock heads into the open after a 1.1 percent dip

At the close on September 7, 2026, Schott Pharma stock finished the Xetra session at EUR 22.95, down 1.1 percent. The move lagged the STOXX 600, which slipped 0.2 percent, while broader market pressure stayed tied to oil and yields.

Schott Pharma stock closed at EUR 22.95 on Xetra on September 7, 2026, down 1.1 percent. The move came as the STOXX 600 fell 0.2 percent on the same session.

September 7, 2026 in numbers

Schott Pharma AG (ISIN DE000A3ENQ51) finished the Xetra session at EUR 22.95, after trading between EUR 22.74 and EUR 23.20. Reuters reported that the broader European market was softer that day, with the STOXX 600 easing 0.2 percent, so Schott Pharma underperformed the regional benchmark by 0.9 percentage point.

Turnover and the narrow range pointed to a muted session rather than a decisive move. The close also left the shares below the broader market backdrop on a day when risk appetite was pressured by higher oil prices and firmer yields, according to Reuters.

Today before the bell

Before the bell, U.S. inflation data and the next move in Treasury yields are the main market items that can shape European sentiment today, as Reuters noted in its market wrap. For Schott Pharma, that backdrop matters through broader health care and risk appetite rather than through a company-specific release.